Pacira BioSciences Inc. (PCRX)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| History |
Portfolio Manager |
Activity ▼ |
Share change |
% change to portfolio |
| Q1 2024 |
| ≡ |
First Eagle Investment Management |
Sell 100.00% |
103,081 |
0.01 |
| Q4 2023 |
| ≡ |
First Eagle Investment Management |
Reduce 50.35% |
104,551 |
0.01 |
| Q3 2023 |
| ≡ |
First Eagle Investment Management |
Reduce 15.00% |
36,640 |
0.00 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
5,823 |
0.00 |
| Q2 2023 |
| ≡ |
First Eagle Investment Management |
Add 38.46% |
67,847 |
0.01 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
5,823 |
0.00 |
| Q1 2023 |
| ≡ |
First Eagle Investment Management |
Add 112.53% |
93,412 |
0.01 |
| Q4 2022 |
| ≡ |
First Eagle Investment Management |
Add 5.71% |
4,482 |
0.00 |
| Q3 2022 |
| ≡ |
First Eagle Investment Management |
Add 12.47% |
8,706 |
0.00 |
| Q2 2022 |
| ≡ |
First Eagle Investment Management |
Add 46.32% |
22,104 |
0.00 |
| Q1 2022 |
| ≡ |
First Eagle Investment Management |
Add 92.18% |
22,889 |
0.00 |
| Q4 2021 |
| ≡ |
First Eagle Investment Management |
Buy |
24,832 |
0.00 |
| Q3 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
1,108 |
0.00 |
| Q2 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
1,108 |
0.00 |
| Q2 2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
48,159 |
0.03 |
| Q1 2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 52.42% |
53,060 |
0.03 |
| Q4 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 41.28% |
71,161 |
0.05 |
| Q3 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
172,380 |
0.10 |
| Q2 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
1,610,932 |
1.35 |
| Q1 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
1,610,932 |
1.35 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.